English 
Spanish 
Throughout May, June, and July, donations made to Parasites Without Borders (PWB) will be matched by the organization and donated to Foundation for International Medical Relief of Children (FIMRC), for a total gift of up to $10,000. Founded in 2002 by Dr. Vikram D. Bakhru, FIMRC is a U.S.-based nonprofit organization that works to improve access to care through innovative, self-sustaining health programs. FIMRC works alongside communities to improve health from the ground up — including building necessary infrastructure, such as constructing or updating buildings; ensuring communities have access to a healthcare professional; and educating on preventive health.
Learn more at fimrc.org
MicrobeTV Podcast
MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.
June 9, 2022
Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management | Children and COVID-19: State level Data Report | FDA Announces Tentative Advisory Committee Meeting Schedule Regarding COVID- 19 Vaccines | FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older | Moderna announces omicron-containing bivalent booster candidate MRNA-1273.214 demonstrates superior antibody response against Omicron
June 2, 2021
IDSA Guideline on the Treatment and Management of COVID-19 with Famotidine | Children and COVID-19: State level Data Report | Duration of viable virus shedding in SARS-CoV-2 omicron variant infection | The association between pre-exposure to glucocorticoids and other immunosuppressant drugs with severe COVID-19 outcomes | Generalizable Long COVID Subtypes: Findings from the NIH N3C and RECOVER Programs | Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic | Tixagevimab/Cilgavimab for Prevention of COVID-19 during the Omicron Surge: Retrospective Analysis of National VA Electronic Data
May 26, 2022
Croup Associated With SARS-CoV-2: Pediatric Laryngotracheitis During the Omicron Surge | Rhinovirus as the main co-circulating virus during the COVID-19 pandemic in children | Children and COVID-19: State-Level Data Report | Infectious viral shedding of SARS-CoV-2 Delta following vaccination: a longitudinal cohort study | Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose | Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States
May 19, 2022
Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection | The Importance of Understanding the Stages of COVID-19 in Treatment and Trials | Supratherapeutic tacrolimus concentrations with Nirmatrelvir/ritonavir in solid organ transplant recipients requiring hospitalization: A case series using rifampin for | Inflammasome activation in infected macrophages drives COVID-19 pathology | Post-acute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases | Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
May 12, 2022
Effect of Early Treatment with Ivermectin among Patients with Covid-19 | Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission | Children and COVID-19: State Date Report | Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age | FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals | Recall of B cell memory depends on relative locations of prime and boost immunization | Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial
May 5, 2022
FDA Updates on Paxlovid for Health Care Providers | SARS-CoV-2 Omicron Variant is as Deadly as Previous Waves After Adjusting for Vaccinations, Demographics, and Comorbidities | Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine
Situation Dashboards
World Health Organization (WHO)
Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
Johns Hopkins University (JHU)
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
COVID-19 in US and Canada
1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
Genomic Epidemiology COVID-19
Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.
